article thumbnail

Diagnosing Pediatric Crohn Disease With Radiomic and Clinical Data

Imaging Technology

milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). Dillman et al.’s and accuracy of 89.6%. and accuracy of 89.6%.

article thumbnail

PET predicts adverse events in heart disease patients

AuntMinnie

PET imaging with nitrogen-13 (N-13) ammonia radiotracer can help predict major adverse cardiac events in patients with ischemic heart disease (IHD), according to a study published May 30 in Radiology: Cardiothoracic Imaging. Patients underwent the scans between January 2017 and January 2021. The full study is available here.

Disease 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Benign breast disease found on percutaneous biopsy ups cancer risk

AuntMinnie

Benign breast disease diagnosed through percutaneous biopsy increases the overall risk of developing breast cancer, according to research published December 13 in JAMA Surgery. Benign breast disease makes up about 75% of breast biopsy diagnoses. The study included data from 4,819 women with a median age of 51.

Disease 122
article thumbnail

Clinical Conundrums: Do We Need to Order a CT for Every Patient with Renal Colic?

REBEL EM

Clinical Scenario: A 35-year-old man with no PMH presents with left flank pain, hematuria and history of kidney stones. Chang 2021 ) This systematic review was used as the basis for a 9 member panel to develop consensus guidelines on CT imaging for patients with suspected renal colic in 29 scenarios. 2021 Sep;47:70-73.

Clinic 60
article thumbnail

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Imaging Technology

Under the agreement, the Philogen Group is conducting a Phase 1 clinical study to evaluate the safety and dosimetry of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) in patients with solid tumors. Philochem discovered and published the first paper on this important tumor targeting ligand in 2021.

article thumbnail

Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the analysis of Neuromelanin-sensitive MRI

Imaging Technology

We believe this technology could become very important in the clinical workflow of patients with neurological and psychiatric disorders.” While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades.

article thumbnail

Siemens Healthineers Announces FDA Clearance of Somatom Pro.Pulse Dual-Source CT Scanner

Imaging Technology

This interest may be attributed in part to a 2021 decision by the American College of Cardiology (ACC) and the American Heart Association (AHA) to give cardiac CT angiography (CCTA) its highest recommendation as a frontline test to evaluate patients with stable and acute chest pain who have no history of coronary artery disease